Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $3.34 billion. The enterprise value is $2.44 billion.

Market Cap	3.34B
Enterprise Value	2.44B

Important Dates

The next estimated earnings date is Wednesday, April 23, 2025, after market close.

Earnings Date	Apr 23, 2025
Ex-Dividend Date	n/a

Share Statistics

VKTX has 112.25 million shares outstanding. The number of shares has increased by 15.57% in one year.

Current Share Class	112.25M
Shares Outstanding	112.25M
Shares Change (YoY)	+15.57%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	74.36%
Float	109.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.77
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 33.09, with a Debt / Equity ratio of 0.00.

Current Ratio	33.09
Quick Ratio	32.93
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,605.54

Financial Efficiency

Return on equity (ROE) is -17.90% and return on invested capital (ROIC) is -15.32%.

Return on Equity (ROE)	-17.90%
Return on Assets (ROA)	-14.78%
Return on Invested Capital (ROIC)	-15.32%
Return on Capital Employed (ROCE)	-17.13%
Revenue Per Employee	n/a
Profits Per Employee	-$3.05M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.69% in the last 52 weeks. The beta is 0.90, so VKTX's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-55.69%
50-Day Moving Average	32.79
200-Day Moving Average	51.45
Relative Strength Index (RSI)	48.59
Average Volume (20 Days)	5,533,150

Short Selling Information

The latest short interest is 25.11 million, so 22.37% of the outstanding shares have been sold short.

Short Interest	25.11M
Short Previous Month	23.93M
Short % of Shares Out	22.37%
Short % of Float	22.87%
Short Ratio (days to cover)	4.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-150.92M
Pretax Income	n/a
Net Income	-109.96M
EBITDA	n/a
EBIT	-150.92M
Earnings Per Share (EPS)	-$1.01

Full Income Statement

Balance Sheet

The company has $902.61 million in cash and $1.12 million in debt, giving a net cash position of $901.49 million or $8.03 per share.

Cash & Cash Equivalents	902.61M
Total Debt	1.12M
Net Cash	901.49M
Net Cash Per Share	$8.03
Equity (Book Value)	880.28M
Book Value Per Share	7.89
Working Capital	879.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-87.79M
Capital Expenditures	n/a
Free Cash Flow	-87.79M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.57%
Shareholder Yield	-15.57%
Earnings Yield	-3.30%
FCF Yield	-2.63%

Dividend Details

Analyst Forecast

The average price target for VKTX is $96.31, which is 223.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$96.31
Price Target Difference	223.95%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2